Ovulation and pregnancy rates with clomiphene citrate
Abstract
A review of recent experience with clomiphene citrate at the Yale-New Haven Medical Center yields the following conclusions: 1) Clomiphene citrate administered at high doses (150 mg and 200 mg) is effective in inducing ovulation in women who would otherwise have failed to conceive if treatment were restricted to only lower dosage regimens. 2) Therapy with clomiphene citrate should be initiated with the 50-mg dose. The 100-mg dose should be reserved for those who fail with the lower dose. 3) Children resulting from clomiphene-induced ovulations appear to be developing normally both mentally and physically. Congenital malformations found in children from clomiphene-induced pregnancies are those seen commonly in general obstetric practice resulting in no significant problems for the children. 4) After 3 ovulations with clomiphene citrate approximately 50% of the patients can be expected to conceive. A 50% conception rate after 3 ovulations with clomiphene citrate does not represent a discrepancy between ovulation rates and pregnancy results, for it agrees statistically with the results obtained for the general population.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Clomiphene results in a 60%-85% ovulation rate and a 10%-20% pregnancy rate per cycle.
“Clomiphene results in a 60%-85% ovulation rate and a 10%-20% pregnancy rate per cycle (2)(3)(4)(5)(6)(7)(8).”
From A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women (2002) · cites this paper as [4]
Cited by
Sorted by citations
Fisher, S. A., Reid, R. L., Van Vugt, D. A., & Casper, R. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03241-7 · Cited by 347 · see citing works
Modern use of clomiphene citrate in induction of ovulation
Κousta, E. (1997) · Human Reproduction Update · doi:10.1093/humupd/3.4.359 · Cited by 327 · see citing works
“As previously mentioned, studies have shown an ovulation rate of 60–85% and a pregnancy rate of 30–40% (MacGregor et al., 1968; Garcia et al., 1977; Gorlitsky et al., 1978; Gysler et al., 1982; Hammond et al., 1984; Dickey et al., 1996).”
BackgroundImani, B., Eijkemans, M. J. C., te Velde, E. R., Habbema, J. D. F., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02929-6 · Cited by 262 · see citing works
Imani, B., Eijkemans, M. J. C., Velde, E. R. T., Habbema, J. D. F., & Fauser, B. C. J. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4919 · Cited by 281 · see citing works
“40–50% of ovulatory women will conceive (3, 5).”
BackgroundThe agonistic-antagonistic properties of clomiphene: A review
Clark, J. H., & Markaverich, B. M. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90055-3 · Cited by 220 · see citing works
Imani, B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.7.2361 · Cited by 184 · see citing works
Wallach, E. E., Donesky, B. W., & Adashi, E. Y. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57408-1 · Cited by 170 · see citing works
Ganie, M. A., Khurana, M. L., Eunice, M., Gulati, M., Dwivedi, S. N., & Ammini, A. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031780 · Cited by 151 · see citing works
Imani, B., Eijkemans, M. J. C., Velde, E. R. T., Habbema, J. D. F., & Fauser, B. C. J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5705 · Cited by 149 · see citing works
“This is in agreement with previous reports in the literature regarding CC (3, 24, 25) and is similar to spontaneous conception chances in normoovulatory women (26).”
BackgroundResultInsulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome
Kashyap, S., Wells, G. A., & Rosenwaks, Z. (2004) · Human Reproduction · doi:10.1093/humrep/deh440 · Cited by 141 · see citing works
“The success rate of CC varies; 80% ovulation and 30–40% pregnancy rates have been reported (Gorlitsky et al., 1978; Lunenfeld et al., 1991; Kousta et al., 1997; Imani et al., 1998, 1999).”
BackgroundComparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis
Steiner, A. Z., Terplan, M., & Paulson, R. J. (2005) · Human Reproduction · doi:10.1093/humrep/deh840 · Cited by 122 · see citing works
“Approximately 80% of women ovulate while using clomiphene (Gorlitsky et al., 1978); however, only 40% of women will achieve pregnancy (Gysler et al.”
BackgroundRelationship of Weight to Successful Induction of Ovulation with Clomiphene Citrate
Shepard, M. K., Balmaceda, J. P., & Leija, C. G. (1979) · Fertility and Sterility · doi:10.1016/s0015-0282(16)44411-0 · Cited by 117 · see citing works
Begum, M. R., Ferdous, J., Begum, A., & Quadir, E. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.08.044 · Cited by 109 · see citing works
Imani, B., Eijkemans, M. J. C., de Jong, F. H., Payne, N. N., Bouchard, P., Giudice, L. C., & Fauser, B. C. J. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6356 · Cited by 112 · see citing works
Reigstad, M. M., Storeng, R., Myklebust, T. Å., Oldereid, N. B., Omland, A. K., Robsahm, T. E., Brinton, L. A., Vangen, S., Furu, K., & Larsen, I. K. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0809 · Cited by 93 · see citing works
“Itmaywell be that women exposed tomany treatment rounds suffer resistant infertility, for example, for women with polycystic ovarian syndrome, only 20% become pregnant with each cycle of clomiphene citrate on average (43, 44).”
BackgroundNeveu, N., Granger, L. R., St-Michel, P., & Lavoie, H. B. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.05.069 · Cited by 92 · see citing works
Cortínez, A., Carvalho, I. D., Vantman, D., Gabler, F., Íñiguez, G., & Vega, M. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.05.099 · Cited by 92 · see citing works
Imani, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.676 · Cited by 90 · see citing works
Imani, B. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1617 · Cited by 81 · see citing works
Amer, S. A., Li, T. C., Metwally, M., Emarh, M., & Ledger, W. L. (2008) · Human Reproduction · doi:10.1093/humrep/den325 · Cited by 73 · see citing works
“Other relatively smaller studies on CC have reported pregnancy rates of 30 – 43% (Garcia et al., 1977; Gorlitsky et al., 1978; Gysler et al., 1982; Hammond, 1984; Dickey et al., 1996; Kousta et al., 1997; Imani et al., 2002).”
Monitoring techniques for improved pregnancy rates during clomiphene ovulation induction
Wallach, E. E., & Hammond, M. G. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48129-x · Cited by 60 · see citing works
Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome
Checa, M. Á., Requena, A., Salvador, C., Tur, R., Callejo, J., Espinós, J. J., Fábregues, F., Herrero, J. C., & (Reproductive Endocrinology Interest Group of the Spanish Society of Fertility) (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi015 · Cited by 60 · see citing works
“Clomiphene citrate has been shown to be effective for induction of ovulation in patients with PCOS, although an ovulation rate of 80% is clearly in contrast to pregnancy rates of 30–40% (Gorlitsky et al., 1978; Lunenfeld et al., 1991; Kousta et al., 1997).”
BackgroundMonitoring plasma concentrations to individualize treatment with clomiphene citrate
Rostami‐Hodjegan, A., Lennard, M. S., Tucker, G. T., & Ledger, W. J. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.07.044 · Cited by 57 · see citing works
Ray, P. B., Ray, A., & Chakraborti, P. S. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2091-7 · Cited by 54 · see citing works
Ovarian Hyperstimulation for Successful in Vitro Fertilization and Embryo Transfer
GRONOW, M. J. (1985) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348509156384 · Cited by 49 · see citing works
Eijkemans, M. J. C., Polinder, S., Mulders, A. G. M. G. J., Laven, J. S. E., Habbema, J. D. F., & Fauser, B. C. J. M. (2005) · Human Reproduction · doi:10.1093/humrep/dei164 · Cited by 44 · see citing works
“4) of patients, despite having been treated for half a year (Gorlitsky et al., 1978; Hammond et al., 1983; Eijkemans et al., 2003).”
BackgroundClinical Uses of Antiestrogens
Baker, V. L., & Jaffe, R. B. (1996) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199601000-00021 · Cited by 42 · see citing works
Sönmez, A. S., Yaşar, L., Savan, K., Koç, S., Ozcan, J., Toklar, A., Yazıcıoğlu, F., Akgün, A., & Süt, N. (2004) · Human Reproduction · doi:10.1093/humrep/deh580 · Cited by 42 · see citing works
“…attempt is 50 mg, which can be increased up to a total daily dose of 150 mg, although a total daily dose of 250 mg has also been used and patients who did not respond to gradual increments of clomiphene citrate treatment are defined as clomiphene citrate resistant (Gorlitsky et al., 1978).”
BackgroundAdverse Effects of Fertility Drugs
Derman, S. G., & Adashi, E. Y. (1994) · Drug Safety · doi:10.2165/00002018-199411060-00003 · Cited by 41 · see citing works
van Gelder, M. M. H. J., den Berg, L. T. W. D. J., & Roeleveld, N. (2013) · Human Reproduction · doi:10.1093/humrep/det370 · Cited by 39 · see citing works
Current and future status of ovulation induction in polycystic ovary syndrome
Messinis, I. E. (1997) · Human Reproduction Update · doi:10.1093/humupd/3.3.235 · Cited by 38 · see citing works
Bedaiwy, M. A., Abdel-Aleem, M. A., Hussein, M., Mousa, N. A., Brunengraber, L. N., & Casper, R. F. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-83 · Cited by 38 · see citing works
“Sub-optimal pregnancy rates with CC have been attributed to peripheral anti-estrogenic effects, mainly on the endometrium and the cervical mucus[3] Gonadotropins are more effective in ovulation induction and are associated with higher pregnancy rates than CC, but are expensive and carry higher risk for ovarian hyperst…”
BackgroundNejad, E. S. T., Abediasl, Z., Rashidi, B. H., Nekoo, E. A., Shariat, M., & Amirchaghmaghi, E. (2008) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-008-9209-2 · Cited by 37 · see citing works
“Clomiphene citrate is an antiestrogenic agent resulting in a 60–85% ovulation rate and 10–20% pregnancy rate per cycle [2–6].”
BackgroundRoumen, F. J. M. E., Doesburg, W. H., & Rolland, R. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)47597-7 · Cited by 33 · see citing works
Clomiphene Stair-Step Protocol for Women With Polycystic Ovary Syndrome
Jones, T. L., Ho, J. R., Gualtieri, M. R., Bruno-Gaston, J., Chung, K., Paulson, R. J., & Bendikson, K. A. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002418 · Cited by 32 · see citing works
Development of Estrogen Antagonists as Pharmaceutical Agents
Ray, S., & Dwivedy, I. (1997) · Advances in Drug Research · doi:10.1016/s0065-2490(97)80015-9 · Cited by 31 · see citing works
Alternate regimens for ovulation induction in polycystic ovarian disease
Wallach, E. E., Kelly, A. C., & Jewelewicz, R. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53688-7 · Cited by 29 · see citing works
Clomiphene Citrate and Pregnancy Outcome
Venn, A., & Lumley, J. A. (1994) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1994.tb01040.x · Cited by 29 · see citing works
Wolf, L. (2000) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-200012000-00020 · Cited by 29 · see citing works
Tailoring treatment for PCOS phenotypes
Papadakis, G. E., Kandaraki, E., Garidou, A., Koutsaki, M., Papalou, O., Diamanti‐Kandarakis, E., & Peppa, Μ. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1865152 · Cited by 27 · see citing works
Deveci, C. D., Demir, B., Şengül, Ö., et al. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3398-y · Cited by 27 · see citing works
“that 52 % of patients ovulate with a CC dose of 50 mg/day, 22 % with 100 mg/day and 12 % with 150 mg/day [4, 5].”
BackgroundLi, Y., Kuang, H., Shen, W., Ma, H., Zhang, Y., Stener‐Victorin, E., Hung, E., Ng, E. H. Y., Liu, J., Kuang, H., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003934 · Cited by 26 · see citing works
Muenstermann, U., & Kleinstein, J. (2000) · Human Reproduction · doi:10.1093/humrep/15.12.2526 · Cited by 25 · see citing works
Begum, M. R., Quadir, E., Begum, A., Begum, R. A., & Begum, M. (2006) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2006.00434.x · Cited by 23 · see citing works
Yland, J. J., Chiu, Y., Rinaudo, P. F., Hsu, J., Hernán, M. Á., & Hernández–Dı́az, S. (2022) · Human Reproduction · doi:10.1093/humrep/deac005 · Cited by 23 · see citing works
Optimizing ovulation induction in women with polycystic ovary syndrome
Seli, E. U., & Dulęba, A. J. (2002) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200206000-00002 · Cited by 23 · see citing works
Ovulation induction techniques in women with polycystic ovary syndrome
Vyrides, A., Mahdi, E. E., & Giannakou, K. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.982230 · Cited by 23 · see citing works
“Even though most women will respond to either 50mg or 100mg (64, 65) as per manufacturer recommendations (66), some clinicians have used doses as high as 250mg (64, 65).”
BackgroundAnovulation and Ovulation Induction
Hammond, M. G. (1984) · CPOBGYN. Clinical perspectives in obstetrics and gynecology · doi:10.1007/978-1-4613-8265-2_6 · Cited by 21 · see citing works
Hofe, J. V., & Bates, G. W. (2014) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2014.09.007 · Cited by 19 · see citing works
Evaluation of an existing nomogram for predicting the response to clomiphene citrate
Ghobadi, C., Nguyen, T. H., Lennard, M. S., Amer, S. A. K. S., Rostami‐Hodjegan, A., & Ledger, W. J. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.10.002 · Cited by 19 · see citing works
A randomized trial comparing the ovulation induction efficacy of clomiphene citrate and letrozole
Ghose, S., Gowda, M. S. S., & Angel, M. (2014) · Journal of Natural Science Biology and Medicine · doi:10.4103/0976-9668.136241 · Cited by 16 · see citing works
“However, the disadvantage is low pregnancy rate of about 50%.[2,3] Letrozole, is a potent, highly specific nonsteroidal aromatase inhibitor with ovulation induction potential and high pregnancy rate of 80%, whichis due to its less antiestrogenic effect on endometrium.”
BackgroundA rational approach to ovulation induction
Wallach, E. E., & PEPPERELL, R. J. (1983) · Fertility and Sterility · doi:10.1016/s0015-0282(16)47169-4 · Cited by 16 · see citing works
SHORT- AND LONG-TERM EFFECTS OF OVULATION INDUCTION
Vollenhoven, B. J., & Healy, D. L. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70046-3 · Cited by 15 · see citing works
Evaluation and Therapy of Polycystic Ovarian Syndrome
Loy, R. A., & Seibel, M. M. (1988) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30410-9 · Cited by 15 · see citing works
Tredway, D. R., Schertz, J. C., Bock, D., Hemsey, G., & Diamond, M. P. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.068 · Cited by 14 · see citing works
Is it safe to prescribe clomiphene citrate without ultrasound monitoring facilities?
Coughlan, C., Fitzgerald, J., Milne, P., & Wingfield, M. B. (2010) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443611003646280 · Cited by 14 · see citing works
“Studies have shown an ovulation rate of 60– 85% and a pregnancy rate of 30–40% (Macgregor et al. 1968; Garcia et al. 1977; Gorlitsky et al. 1978; Gysler et al. 1982; Hammond 1984; Dickey et al. 1996).”
BackgroundAchieving a Successful Pregnancy in Women with Polycystic Ovary Syndrome
Araki, T., Elias, R. T., Rosenwaks, Z., & Poretsky, L. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.08.003 · Cited by 13 · see citing works
Stone, S. C., Schimberni, M., Schuster, P. A., et al. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59429-1 · Cited by 10 · see citing works
Milsom, S. R., Gibson, G., Buckingham, K., & Gunn, A. J. (2002) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.0004-8666.2002.00170.x · Cited by 9 · see citing works
Epimestrol in Treatment of Inadequate Luteal Progesterone Secretion
Bohnet, H. G., Hanker, J. P., Hilland, U., et al. (1980) · Fertility and Sterility · doi:10.1016/s0015-0282(16)45020-x · Cited by 8 · see citing works
Greenblatt, E. M. (1993) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(05)80138-5 · Cited by 8 · see citing works
Sharma, S., Choudhary, M., Swarankar, V., & Vaishnav, V. (2021) · Journal of Reproduction & Infertility · doi:10.18502/jri.v22i4.7653 · Cited by 7 · see citing works
“It is known that higher doses of clomiphene results in better ovulation rates (6), but the antiestrogenic effect on endometrium is more with higher doses (31, 32); thus, the higher ovulation rates are not translated into higher pregnancy rates.”
BackgroundPrevention of Multiple Pregnancy During Ovulation Induction
Hale, L. (2003) · Twin Research · doi:10.1375/136905203322686563 · Cited by 8 · see citing works
“The pregnancy rate per induced ovulatory cycle is 15–20% (Gorlitsky et al., 1978).”
BackgroundMeirow, D., Laufer, N., & Schenker, J. G. (1993) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(93)90176-d · Cited by 7 · see citing works
Kennedy, J. L., & Adashi, E. Y. (1987) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(21)00591-x · Cited by 7 · see citing works
Shahin, A. Y. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60407-5 · Cited by 7 · see citing works
Fedele, L., Marchini, M., Baglioni, A., Dorta, M., & Candiani, G. B. (1988) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348809004277 · Cited by 6 · see citing works
Chin, P. Y., Chan, H. Y., Kieffer, T. E. C., Prins, J. R., Russell, D. L., Davies, M. J., & Robertson, S. A. (2024) · Endocrinology · doi:10.1210/endocr/bqae047 · Cited by 5 · see citing works
Giants in Obstetrics and Gynecology Series: A profile of Leon Speroff, MD
Romero, R. J. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.05.056 · Cited by 5 · see citing works
Medical Treatment of Infertility
Decker, W. (1987) · Springer eBooks · doi:10.1007/978-1-4613-2157-6_31 · Cited by 5 · see citing works
The effects of 3-day clomiphene citrate treatment on endocrine and ovulatory responses
Göl, K., Gursoy, R., Karabacak, O., & Yildirim, M. (1996) · Gynecological Endocrinology · doi:10.3109/09513599609027985 · Cited by 4 · see citing works
Faso, C. (2025) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2025.01.004 · Cited by 3 · see citing works
(2012) · InTech eBooks · doi:10.5772/1279 · Cited by 3 · see citing works
Najim, H. D., Al-khfajy, W. S., Albasry, Z., & Al‐Taie, A. (2023) · International Journal of Academic Medicine · doi:10.4103/ijam.ijam_90_22 · Cited by 2 · see citing works
Reappraisal of the use of clomifene for ovulation induction
Bekhit, M., & Greenwood, P. (2005) · The Obstetrician & Gynaecologist · doi:10.1576/toag.7.1.014.27037 · Cited by 2 · see citing works
Clomiphene versus letrozole: a better agent for ovulation induction
Maji, A., Ramani, M. V., & Kiran, K. (2020) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20204303 · Cited by 2 · see citing works
“International Journal of Reproduction, Contraception, Obstetrics and Gynecology Volume 9 · Issue 10 Page 4146 receptors, hence inhibiting endometrial growth.(3,4) Letrozole is a potent nonsteroidal aromatase inhibitor which results in ovulation induction.”
BackgroundPrevention of Multiple Pregnancy During Ovulation Induction
Hale, L. (2003) · Twin Research · doi:10.1375/twin.6.6.540 · Cited by 2 · see citing works
“The pregnancy rate per induced ovulatory cycle is 15–20% (Gorlitsky et al., 1978).”
BackgroundReproductive Performance of Previously Infertile Couples
Worley, R. J., & Keye, W. R. (1984) · CPOBGYN. Clinical perspectives in obstetrics and gynecology · doi:10.1007/978-1-4613-8265-2_18 · Cited by 2 · see citing works
Rabe, T., Bruyniks, N., Merkle, E. C., et al. (2016) · Journal für Reproduktionsmedizin und Endokrinologie · Cited by 1 · see citing works
Dokras, A., & Sivitz, W. I. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-378-1_9 · Cited by 2 · see citing works
Luk, J., & Patrizio, P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139192736.027 · Cited by 1 · see citing works
ART: skills, techniques and present status
Coward, K., & Wells, D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139192736.025 · Cited by 1 · see citing works
Mikołajczyk, M., Goździewicz, T., & Skrzypczak, J. (2013) · Ginekologia Polska · doi:10.17772/gp/1650 · Cited by 1 · see citing works
Ivy, R., Chowdhury, A., Haque, K., & Ara, H. (1970) · Bangladesh Journal of Physiology and Pharmacology · doi:10.3329/bjpp.v25i1.5739 · Cited by 1 · see citing works
The Role of Assisted Reproduction in the Cancer Patient
Patrizio, P., & Levi-Setti, P. E. (2016) · Current clinical urology · doi:10.1007/978-3-319-27711-0_15 · Cited by 1 · see citing works
Dasari, P., Saravanan, K., & Rajappan, M. (2016) · Fertility Science and Research · doi:10.4103/fsr.fsr_1_17 · Cited by 1 · see citing works
“Pregnancy rate in this series was 8%, which is very low compared to 30 to 40% rates of previous studies.([21-24])”
ResultBhat, I. A. (2021) · Journal of Gynecology and Womens Health · doi:10.19080/jgwh.2021.21.556055 · Cited by 1 · see citing works
“8% and other benefits were ascertained as well [36].”
Pregnancy Rate and First-Trimester Outcome Following Ovulation Induction
Oelsner, G., Bider, D., & Mashiach, S. (1992) · Springer eBooks · doi:10.1007/978-3-642-84385-3_12 · Cited by 1 · see citing works
Praktisches Vorgehen bei gestörter Ovarfunktion
Leidenberger, F. A. (1992) · Springer eBooks · doi:10.1007/978-3-662-08110-5_24 · Cited by 1 · see citing works
Praktisches Vorgehen bei gestörter Ovarfunktion und mit ihr assoziierten Phänomenen
Leidenberger, F. A. (1998) · Springer eBooks · doi:10.1007/978-3-662-08108-2_24 · Cited by 1 · see citing works
Spontaneous abortion following ovulation induction
Spirtos, N. J., Hayes, M. F., Magyar, D. M., & Cossler, N. (1984) · Springer eBooks · doi:10.1007/978-94-010-9789-5_6 · Cited by 1 · see citing works
Prediction of ovulation induction outcome in normogonadotropic anovulatory infertility
Imani, B. (2002) · RePub (Erasmus University Rotterdam)
Pregnancy following induction of ovulation with clomiphene
Masson, G. M., & Harris, D. W. (1982) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443618209083073
Valencia, N. Q., Rabanal, M., Scaletti, S., Rechkemmer, A. F., & Rodríguez, D. (2015) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v56i242
Nsoy, G. E. ‹., & N, G. T. ‹. (2003)
Decremental Follicle-Stimulating Hormone and Single Dominant Follicle Selection in the Human
van Santbrink, E. J. P. (1998) · EUR Research Repository (Erasmus University Rotterdam)
Clinical Outcomes of Tamoxifen and Clomiphene Citrate in Intrauterine Insemination Cycles
Majeed, A., & Divyashree, P. S. (2015) · International Journal of Infertility & Fetal Medicine · doi:10.5005/jp-journals-10016-1113
“Obstet Gynecol 1978 Mar;51(3):265269.”
BackgroundInfluentialHypothalamic and Pituitary Disorders in Reproduction
PEPPERELL, R. J. (1988) · Springer eBooks · doi:10.1007/978-94-009-2625-7_1
- Authors
- GORLITSKY, G. A., KASE, N. G., & SPEROFF, L.
- Affiliations
- Yale University (US)
- Venue
- Obstetrics & Gynecology
- Published
- 1978-03
- Volume
- 51
- Issue
- 3
- Pages
- 265-269
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2167352241
- Cited by
- 99
- References
- 0
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2017: 3 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 5 · 2012: 1
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- clomiphene citrate, ovulation induction, pregnancy rate, dose-response relationship, infertility, congenital malformations, child development, ovulation rate
- MeSH terms
- Abnormalities, Drug-Induced, Adult, Child Development, Child, Preschool, Clomiphene, Female, Fetus, Follow-Up Studies, Humans, Menstruation Disturbances, Ovulation, Ovulation Induction, Pregnancy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
